Oncology & Cancer

Machine learning that predicts anti-cancer drug efficacy

With the advent of pharmacogenomics, machine learning research is well underway to predict patients' drug response that varies by individual from the algorithms derived from previously collected data on drug responses. Entering ...

Oncology & Cancer

Chemotherapy with a reduction of negative consequences

Cancer metastases, the main cause of cancer-related mortality, are sometimes triggered by successful chemotherapy. A research group at the Rappaport Faculty of Medicine analyzed this phenomenon and demonstrated ways of intervening ...

Oncology & Cancer

Balance of two enzymes linked to pancreatic cancer survival

Protein Kinase C (PKC) enzymes are crucial for a number of cellular activities, including cell survival, proliferation and migration—functions that must be carefully controlled lest cells get out of control and form a tumor. ...

Medications

Cocktail proves toxic to leukemia cells

A combination of drugs that affect mitochondria—the power plants inside cells—may become the best weapons yet to fight acute myeloid leukemia, according to Rice University researchers.

Oncology & Cancer

How prostate cancer becomes treatment resistant

The development of effective anti-androgen therapies for prostate cancer is a major scientific advance. However, some men who receive these targeted treatments are more likely to develop a deadly treatment-resistant prostate ...

Genetics

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

page 4 from 19